{"disease":{"id":"chronic-idiopathic-constipation","name":"Chronic idiopathic constipation","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":6,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"prucalopride","indication_name":"Chronic Idiopathic Constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PRUCALOPRIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"linaclotide","indication_name":"Chronic idiopathic constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Linzess","generic_name":"LINACLOTIDE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Heat-stable enterotoxin receptor","drug_class":"Guanylate Cyclase-C Agonist [EPC]","quality_score":57,"revenue":null,"mechanism":"Linzess works by activating the heat-stable enterotoxin receptor to increase fluid secretion in the intestines."},{"drug_id":"linzess","indication_name":"Chronic idiopathic constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Linzess","company_name":"TriHealth Inc.","drug_phase":"discontinued","molecular_target":"Heat-stable enterotoxin receptor, Heat-stable enterotoxin receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"lactitol","indication_name":"Chronic idiopathic constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pizensy","generic_name":"LACTITOL","company_name":"Braintree Labs","drug_phase":"marketed","molecular_target":"","drug_class":"Osmotic Laxative","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"lubiprostone","indication_name":"Chronic idiopathic constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amitiza","generic_name":"LUBIPROSTONE","company_name":"Sucampo Pharma Llc","drug_phase":"marketed","molecular_target":"Chloride channel protein 2","drug_class":"Chloride Channel Activator [EPC]","quality_score":65,"revenue":null,"mechanism":"Amitiza works by activating chloride channels in the intestines, increasing fluid secretion and promoting bowel movements."},{"drug_id":"tegaserod","indication_name":"Chronic idiopathic constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zelnorm","generic_name":"TEGASEROD","company_name":"","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2B","drug_class":"Serotonin-4 Receptor Agonist","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"plecanatide","indication_name":"Chronic idiopathic constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trulance","generic_name":"PLECANATIDE","company_name":"Salix","drug_phase":"marketed","molecular_target":"Tumor necrosis factor","drug_class":"Guanylate Cyclase-C Agonist [EPC]","quality_score":65,"revenue":null,"mechanism":"Trulance works by stimulating the guanylate cyclase-C receptor to increase fluid secretion in the intestines."}],"pipeline":[],"offLabel":[],"totalMarketed":7,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT02590432","title":"An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":828,"lead_sponsor_name":"Forest Laboratories","has_results":true},{"nct_id":"NCT04804267","title":"Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":750,"lead_sponsor_name":"Jiangsu Hansoh Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07382167","title":"A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":692,"lead_sponsor_name":"Ardelyx","has_results":false},{"nct_id":"NCT03097861","title":"Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":552,"lead_sponsor_name":"Sucampo Pharma Americas, LLC","has_results":true},{"nct_id":"NCT03879239","title":"Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation","phase":"NA","overall_status":"COMPLETED","enrollment_count":349,"lead_sponsor_name":"Vibrant Ltd.","has_results":true},{"nct_id":"NCT07388589","title":"Soluble and Osmotic Fibre (SOLOS) Diet for Constipation","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Singapore Institute of Technology","has_results":false},{"nct_id":"NCT02695719","title":"Lubiprostone for Treatment of Chronic Idiopathic Constipation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":156,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04869280","title":"Post-Marketing Study of Prucalopride Safety In Pregnancy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":127,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT05652205","title":"A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":123,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT06349031","title":"Comparison of Efficacy & Tolerability Of PEG 4000 Versus PEG 3350+ Electrolytes for Pediatric Fecal Disimpaction","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Institute of Medical Sciences and SUM Hospital","has_results":false},{"nct_id":"NCT07431957","title":"\"Efficacy and Safety of Linaclotide in Chronic Constipation\"","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Md Mehedi Shahriar","has_results":false},{"nct_id":"NCT04666155","title":"MOWOOT Device Treatment for Adults With Chronic Constipation","phase":"NA","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"usMIMA S.L.","has_results":false},{"nct_id":"NCT06736912","title":"This Study Aims to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties and Food Effect of IN-114199 in Healthy Participants","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"HK inno.N Corporation","has_results":false},{"nct_id":"NCT04458675","title":"Efficacy and Safety of Vibrant Capsule vs. Vibrant Placebo for the Treatment of Chronic Idiopathic Constipation (CIC)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"Vibrant Ltd.","has_results":true},{"nct_id":"NCT03054506","title":"The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation","phase":"NA","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT04838522","title":"A Study of Prucalopride in Breastfeeding Women With Constipation","phase":"","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT03551873","title":"A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®","phase":"","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}